Telaprevir in a Patient with Chronic Hepatitis C and Cryoglobulinemic Glomerulonephritis
Stella De Nicola(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Massimo Colombo(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Alessio Aghemo, Maria Grazia Rumi(University of Milan), Maria Rosaria Campise(University of Milan), Piergiorgio Messa(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Roberta D’Ambrosio(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)
Cited by 21
Related Papers
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
|Journal of Hepatology|2001|4.1k
Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
|New England Journal of Medicine|2004|1.1k
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
|The Lancet. Gastroenterology & hepatology|2022|664
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.
|Journal of Clinical Investigation|1996|661
The natural history of compensated cirrhosis due to hepatitis C virus
|Hepatology|2006|631